Percutaneous osteoplasty and interventions in VBCF – online course
Description
Please note that this course is no longer CME accredited, but we are working on a new accredited version.
Authors: X. Buy, R. Cazzato and P. Lohle
Reviewers: F. Deschamps, M. Deutschmann, D. Filippiadis, G. Mauri and C. Nice
This course corresponds to chapters 2.2.4.4 Percutaneous Osteoplasty and 2.2.4.5.1 Interventions in Vertebral Body Compression Fractures (VBCF) in the European Curriculum and Syllabus for IR.
Abstract
Percutaneous vertebroplasty is applied for the treatment of benign osteoporotic or malignant osteolytic vertebral body fractures. The procedure relies on poly(methyl methacrylate) (PMMA) injection inside the vertebral body in order to consolidate the fracture, achieve effective pain control and prevent further vertebral collapse. The aim of this course is to present the indications and contraindications of percutaneous vertebroplasty, and describe the technique and the devices that are commonly used.
Learning objectives
- Learn the basics of percutaneous vertebral augmentation.
- Learn the indications and contraindications of percutaneous treatment in benign and malignant vertebral compression fractures (VCFs).
- Learn about the correct material needed for percutaneous vertebroplasty.
- Learn about the percutaneous vertebral approach at cervical, thoracic, lumbar and sacral levels.
- Learn how to avoid complications.
Further information
This course covers a basic level of IR knowledge and is designed for trainees, students or young consultants aiming to acquire essential knowledge or prepare for the EBIR exam. Thereby, it is tailored to the European Curriculum and Syllabus for IR and corresponds to chapters 2.2.4.4 Percutaneous Osteoplasty and 2.2.4.5.1 Interventions in Vertebral Body Compression Fractures (VBCF).
The format of the course is interactive and easy to use, including texts, graphics, videos and a quiz to support your learning. The course duration is around one hour.
The enrolment period of this course is set to 90 days and may be extended throughout the year with a valid All-Access Pass.
Release date: March 2019
